Abstract
The COVID pandemic resulted in a surge of critically ill patients to New York hospitals. COVID is associated with a systemic inflammatory response that can result in abnormal laboratory parameters and imaging findings of cholestasis, making the diagnosis and treatment of cholecystitis difficult Given the shift to nonsurgical approaches for patients with COVID, interventional radiology (IR) became even more critical in the management of these patients. We report the percutaneous cholecystostomy experience of the largest hospital system in New York during the height of the COVID pandemic.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
